Pleiotropic Analysis of Lung Cancer and Blood Triglycerides.
Zuber V., Marconett CN., Shi J., Hua X., Wheeler W., Yang C., Song L., Dale AM., Laplana M., Risch A., Witoelar A., Thompson WK., Schork AJ., Bettella F., Wang Y., Djurovic S., Zhou B., Borok Z., van der Heijden HFM., de Graaf J., Swinkels D., Aben KK., McKay J., Hung RJ., Bikeböller H., Stevens VL., Albanes D., Caporaso NE., Han Y., Wei Y., Panadero MA., Mayordomo JI., Christiani DC., Kiemeney L., Andreassen OA., Houlston R., Amos CI., Chatterjee N., Laird-Offringa IA., Mills IG., Landi MT.
Epidemiologically related traits may share genetic risk factors, and pleiotropic analysis could identify individual loci associated with these traits. Because of their shared epidemiological associations, we conducted pleiotropic analysis of genome-wide association studies of lung cancer (12 160 lung cancer case patients and 16 838 control subjects) and cardiovascular disease risk factors (blood lipids from 188 577 subjects, type 2 diabetes from 148 821 subjects, body mass index from 123 865 subjects, and smoking phenotypes from 74 053 subjects). We found that 6p22.1 (rs6904596, ZNF184) was associated with both lung cancer (P = 5.50x10(-6)) and blood triglycerides (P = 1.39x10(-5)). We replicated the association in 6097 lung cancer case patients and 204 657 control subjects (P = 2.40 × 10(-4)) and in 71 113 subjects with triglycerides data (P = .01). rs6904596 reached genome-wide significance in lung cancer meta-analysis (odds ratio = 1.15, 95% confidence interval = 1.10 to 1.21 ,: Pcombined = 5.20x10(-9)). The large sample size provided by the lipid GWAS data and the shared genetic risk factors between the two traits contributed to the uncovering of a hitherto unidentified genetic locus for lung cancer.